ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xeplion 150 mg, Depot-Injektionssuspension in einer Fertigspritze - Spritze(n)
60466005 Janssen-Cilag AG
Xeplion 150 mg, Depot-Injektionssuspension in einer Fertigspritze15.12.2010
Original15.12.2010
Paliperidone (N05AX13) 
WHO-DDD 
01.05.Spritze(n)
01.05. 
B  
Yes 
IP 
435.39No
    
10 %477.85
  
7680604660058Synthetika
4787830 
Composition
paliperidonum 150 mg ut paliperidoni palmitas 234 mg, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1.5 ml corresp. natrium 5.503 mg.
Packungsbestandteile
Retardsuspension zur intramuskulären Injektion 
  
 
Active AgentDose
Paliperidonum150 mg
BAG: Active AgentDose
Paliperidonum150 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Disodium Phosphate 
Macrogol4000
Sodium Dihydrogenophosphate Monohydrate 
Sodium Hydroxide 
Polysorbatum 20 
 
Source
Data was imported : 04.10.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home